TY - JOUR
T1 - I prevent bacterial resistance. an update on the use of antibiotics in dermatologic surgery
AU - Moorhead, Christine
AU - Torres, Abel
N1 - BACKGROUND AND OBJECTIVES Prophylaxis may be given to prevent a surgical wound infection, infective endocarditis (IE), or infection of a prosthetic joint, but its use before cutaneous surgery is co...
PY - 2009/10
Y1 - 2009/10
N2 - BACKGROUND AND OBJECTIVES Prophylaxis may be given to prevent a surgical wound infection, infective endocarditis (IE), or infection of a prosthetic joint, but its use before cutaneous surgery is controversial. Our aim was to review the current literature and provide a mnemonic to assist providers in appropriately prescribing prophylactic antibiotics. METHODS AND MATERIALS We reviewed the current literature, including the new guidelines provided by the American Heart Association (AHA). RESULTS The new AHA guidelines recommend prophylaxis for patients with high risk of an adverse outcome from IE instead of high risk of developing IE. The American Academy of Orthopedic Surgeons and the American Dental Association also provide guidelines. Given the paucity of conclusive studies, prophylaxis against a surgical wound infection is based more on clinical judgment. CONCLUSION The mnemonic we propose, "I PREVENT," represents: Immunosuppressed patients; patients with a Prosthetic valve; some patients with a joint Replacement; a history of infective Endocarditis; a Valvulopathy in cardiac transplant recipients; Endocrine disorders such as uncontrolled diabetes mellitus; Neonatal disorders including unrepaired cyanotic heart disorders (CHDs), repaired CHD with prosthetic material, or repaired CHD with residual defects; and the Tetrad of antibiotics: amoxicillin, cephalexin, clindamycin, and ciprofloxacin. The authors have indicated no significant interest with commercial supporters. © 2009 by the American Society for Dermatologic Surgery, Inc.
AB - BACKGROUND AND OBJECTIVES Prophylaxis may be given to prevent a surgical wound infection, infective endocarditis (IE), or infection of a prosthetic joint, but its use before cutaneous surgery is controversial. Our aim was to review the current literature and provide a mnemonic to assist providers in appropriately prescribing prophylactic antibiotics. METHODS AND MATERIALS We reviewed the current literature, including the new guidelines provided by the American Heart Association (AHA). RESULTS The new AHA guidelines recommend prophylaxis for patients with high risk of an adverse outcome from IE instead of high risk of developing IE. The American Academy of Orthopedic Surgeons and the American Dental Association also provide guidelines. Given the paucity of conclusive studies, prophylaxis against a surgical wound infection is based more on clinical judgment. CONCLUSION The mnemonic we propose, "I PREVENT," represents: Immunosuppressed patients; patients with a Prosthetic valve; some patients with a joint Replacement; a history of infective Endocarditis; a Valvulopathy in cardiac transplant recipients; Endocrine disorders such as uncontrolled diabetes mellitus; Neonatal disorders including unrepaired cyanotic heart disorders (CHDs), repaired CHD with prosthetic material, or repaired CHD with residual defects; and the Tetrad of antibiotics: amoxicillin, cephalexin, clindamycin, and ciprofloxacin. The authors have indicated no significant interest with commercial supporters. © 2009 by the American Society for Dermatologic Surgery, Inc.
KW - Dermatologic Surgical Procedures
KW - Anti-Bacterial Agents/administration & dosage
KW - Humans
KW - Endocarditis/prevention & control
KW - Antibiotic Prophylaxis
KW - Prosthesis-Related Infections/prevention & control
KW - Surgical Wound Infection/prevention & control
UR - http://www.scopus.com/inward/record.url?scp=70349895390&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70349895390&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/663602ab-9f77-3340-92a6-b37a4ecdbabf/
U2 - 10.1111/j.1524-4725.2009.01269.x
DO - 10.1111/j.1524-4725.2009.01269.x
M3 - Article
C2 - 19686361
SN - 1076-0512
VL - 35
SP - 1532
EP - 1538
JO - Dermatologic Surgery
JF - Dermatologic Surgery
IS - 10
ER -